Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-07-02

Clinical Trial Update: Exposure to Neurotoxins as Risk Factors for Amyotrophic Lateral Sclerosis

View source ↗

Summary

A completed clinical trial investigates whether exposure to environmental neurotoxins is a risk factor for amyotrophic lateral sclerosis (ALS).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Environmental Health Sciences (NIEHS) | Conditions: Amyotrophic Lateral Sclerosis, ALS | Status: COMPLETED